Bank of New York Mellon’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.49M | Buy |
388,037
+102,113
| +36% | +$1.18M | ﹤0.01% | 2321 |
|
|
2025
Q1 | $2.5M | Sell |
285,924
-4,107
| -1% | -$35.9K | ﹤0.01% | 2570 |
|
|
2024
Q4 | $4.16M | Sell |
290,031
-45,337
| -14% | -$651K | ﹤0.01% | 2375 |
|
|
2024
Q3 | $7.57M | Buy |
335,368
+7,187
| +2% | +$162K | ﹤0.01% | 2076 |
|
|
2024
Q2 | $6.38M | Sell |
328,181
-522,634
| -61% | -$10.2M | ﹤0.01% | 2205 |
|
|
2024
Q1 | $31.9M | Sell |
850,815
-96,578
| -10% | -$3.62M | 0.01% | 1302 |
|
|
2023
Q4 | $53M | Sell |
947,393
-62,863
| -6% | -$3.52M | 0.01% | 1007 |
|
|
2023
Q3 | $41.7M | Buy |
1,010,256
+122,981
| +14% | +$5.07M | 0.01% | 1109 |
|
|
2023
Q2 | $49.5M | Buy |
887,275
+89,127
| +11% | +$4.98M | 0.01% | 1024 |
|
|
2023
Q1 | $44.5M | Sell |
798,148
-14,551
| -2% | -$812K | 0.01% | 1079 |
|
|
2022
Q4 | $29.6M | Buy |
812,699
+1,341
| +0.2% | +$48.9K | 0.01% | 1319 |
|
|
2022
Q3 | $23.1M | Sell |
811,358
-18,602
| -2% | -$530K | 0.01% | 1417 |
|
|
2022
Q2 | $37.6M | Sell |
829,960
-4,140
| -0.5% | -$187K | 0.01% | 1161 |
|
|
2022
Q1 | $63.5M | Buy |
834,100
+87,322
| +12% | +$6.64M | 0.01% | 942 |
|
|
2021
Q4 | $111M | Sell |
746,778
-7,127
| -0.9% | -$1.06M | 0.02% | 651 |
|
|
2021
Q3 | $110M | Buy |
753,905
+22,085
| +3% | +$3.22M | 0.02% | 632 |
|
|
2021
Q2 | $143M | Sell |
731,820
-66,799
| -8% | -$13.1M | 0.03% | 535 |
|
|
2021
Q1 | $145M | Buy |
798,619
+49,088
| +7% | +$8.88M | 0.03% | 530 |
|
|
2020
Q4 | $106M | Buy |
749,531
+101,766
| +16% | +$14.4M | 0.02% | 622 |
|
|
2020
Q3 | $80.8M | Buy |
647,765
+60,976
| +10% | +$7.6M | 0.02% | 666 |
|
|
2020
Q2 | $52.4M | Buy |
586,789
+123,031
| +27% | +$11M | 0.01% | 855 |
|
|
2020
Q1 | $28.9M | Buy |
463,758
+286,253
| +161% | +$17.8M | 0.01% | 1058 |
|
|
2019
Q4 | $13.5M | Buy |
177,505
+171,516
| +2,864% | +$13.1M | ﹤0.01% | 1807 |
|
|
2019
Q3 | $302K | Buy |
+5,989
| New | +$302K | ﹤0.01% | 3773 |
|